Choosing the right timing for interval debulking surgery and perioperative chemotherapy may improve the prognosis of advanced epithelial ovarian cancer: a retrospective study

Choosing the right timing for interval debulking surgery and perioperative chemotherapy may improve the prognosis of advanced epithelial ovarian cancer: a retrospective study

Abstract Background Primary debulking surgery (PDS) is the main treatment for patients with advanced ovarian cancer, and neoadjuvant chemotherapy (NACT) is for bulky stage III-IV patients who are poor surgical candidates and/or for whom there is a low likelihood of optimal cytoreduction. NACT can in...

Full description

Bibliographic Details
Main Authors: Dengfeng Wang, Guonan Zhang, Chunrong Peng, Yu Shi, Xunwei Shi
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Journal of Ovarian Research
Subjects:
Ovarian cancer
Neoadjuvant chemotherapy
Surgery
CA125
Prognosis
Online Access:https://doi.org/10.1186/s13048-021-00801-4

Similar Items

Similar Items